Evidence map›Paper›PMID 39496837›Full record

ArticleScientific reports2024

IFN-γ derived from activated human CD4

Jun Shimizu, Tadahiro Sasaki, Guang Han Ong, Ritsuko Koketsu, Yoshihiro Samune, Emi E Nakayama, Tetsuharu Nagamoto, Yuki Yamamoto, Kazuo Miyazaki, Tatsuo Shioda

Abstract read
In one paragraph

Article in Scientific reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Human T Cell Responses to Flavivirus Vaccines.European journal of immunology · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Jun ShimizuMiCAN Technologies Inc., KKVP 1-36, Goryo-Ohara, Nishikyo-Ku, Kyoto, 615-8245, Japan.
Tadahiro SasakiDepartment of Viral Infections, Research Institute for Microbial Diseases, Osaka University, 3-1, Yamada-Oka, Suita, Osaka, 565-0871, Japan.
Guang Han OngMiCAN Technologies Inc., KKVP 1-36, Goryo-Ohara, Nishikyo-Ku, Kyoto, 615-8245, Japan.
Ritsuko KoketsuDepartment of Viral Infections, Research Institute for Microbial Diseases, Osaka University, 3-1, Yamada-Oka, Suita, Osaka, 565-0871, Japan.
Yoshihiro SamuneDepartment of Viral Infections, Research Institute for Microbial Diseases, Osaka University, 3-1, Yamada-Oka, Suita, Osaka, 565-0871, Japan.
Emi E NakayamaDepartment of Viral Infections, Research Institute for Microbial Diseases, Osaka University, 3-1, Yamada-Oka, Suita, Osaka, 565-0871, Japan.
Tetsuharu NagamotoHiLung Inc., Innovation Hub Kyoto, 46-29, Yoshida Shimoadachi-cho, Sakyo-ku, Kyoto, 606-8304, Japan.
Yuki YamamotoHiLung Inc., Innovation Hub Kyoto, 46-29, Yoshida Shimoadachi-cho, Sakyo-ku, Kyoto, 606-8304, Japan.
Kazuo MiyazakiMiCAN Technologies Inc., KKVP 1-36, Goryo-Ohara, Nishikyo-Ku, Kyoto, 615-8245, Japan. kmiyazaki@micantechnologies.com.
Tatsuo ShiodaDepartment of Viral Infections, Research Institute for Microbial Diseases, Osaka University, 3-1, Yamada-Oka, Suita, Osaka, 565-0871, Japan. shioda@biken.osaka-u.ac.jp.

Funding

the Japan Agency for Medical Research and Development (AMED) JP20he0822004
6 · The paper itself

Abstract

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and vaccination elicit both T cell and B cell immune responses in immunocompetent individuals. However, the mechanisms underlying the antiviral effects mediated by CD4

Indexed as

CD4-Positive T-LymphocytesCOVID-19Interferon-gammaSARS-CoV-2Virus ReplicationChlorocebus aethiopsHumansLymphocyte ActivationVero CellsInterferon-gamma

Identifiers

PMID39496837
PMCPMC11535250

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.